Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and Northeast Asian populations
- PMID: 16222679
- DOI: 10.1002/ajmg.a.30978
Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and Northeast Asian populations
Abstract
Fukuyama-type congenital muscular dystrophy (FCMD), one of the most common autosomal recessive disorders in Japan, is characterized by congenital muscular dystrophy associated with brain malformation due to a defect in neuronal migration. Previously, we identified the gene responsible for FCMD, which encodes the fukutin protein. Most FCMD-bearing chromosomes (87%) are derived from a single ancestral founder, who lived 2,000-2,500 years ago and whose mutation consisted of a 3-kb retrotransposal insertion in the 3' non-coding region of the fukutin gene. Here we show, through detailed sequence analysis, that the founder insertion is derived from the SINE-VNTR-Alu (SVA) retroposon. To enable rapid detection of this insertion, we have developed a PCR-based diagnostic method that uses three primers simultaneously. We used this method to investigate the distribution and origin of the founder insertion, screening a total of 4,718 control DNA samples from Japanese and other Northeast Asian populations. Fifteen founder chromosomes were detected among 2,814 Japanese individuals. Heterozygous carriers were found in various regions throughout Japan, with an averaged ratio of 1 in 188. In Korean populations, we detected one carrier in 935 individuals. However, we were unable to detect any heterozygous alleles in 203 Mongolians and 766 Mainland Chinese populations. These data largely rule out the possibility that a single ancestor bearing an insertion-chromosome immigrated to Japan from Korea or Mainland China and appear to confirm that FCMD carriers are rare outside of Japan.
Copyright 2005 Wiley-Liss, Inc
Similar articles
-
A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy.Am J Med Genet A. 2004 May 15;127A(1):54-57. doi: 10.1002/ajmg.a.20669. Am J Med Genet A. 2004. PMID: 15103718
-
Age and origin of the FCMD 3'-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population.Hum Genet. 2000 Dec;107(6):559-67. doi: 10.1007/s004390000421. Hum Genet. 2000. PMID: 11153909
-
Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD).Hum Mol Genet. 1999 Nov;8(12):2303-9. doi: 10.1093/hmg/8.12.2303. Hum Mol Genet. 1999. PMID: 10545611
-
Fukuyama-type congenital muscular dystrophy: the first human disease to be caused by an ancient retrotransposal integration.J Mol Med (Berl). 1999 Dec;77(12):816-23. doi: 10.1007/s001099900065. J Mol Med (Berl). 1999. PMID: 10682317 Review.
-
The Fukuyama congenital muscular dystrophy story.Neuromuscul Disord. 2000 Mar;10(3):153-9. doi: 10.1016/s0960-8966(99)00109-1. Neuromuscul Disord. 2000. PMID: 10734260 Review.
Cited by
-
Mechanisms of disease-associated SINE-VNTR-Alus.Exp Biol Med (Maywood). 2022 May;247(9):756-764. doi: 10.1177/15353702221082612. Epub 2022 Apr 6. Exp Biol Med (Maywood). 2022. PMID: 35387528 Free PMC article. Review.
-
Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families.Prenat Diagn. 2009 Jun;29(6):560-9. doi: 10.1002/pd.2238. Prenat Diagn. 2009. PMID: 19266496 Free PMC article.
-
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy.Nature. 2011 Oct 5;478(7367):127-31. doi: 10.1038/nature10456. Nature. 2011. PMID: 21979053 Free PMC article.
-
Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance.Neurol Ther. 2019 Dec;8(2):397-409. doi: 10.1007/s40120-019-00157-4. Epub 2019 Sep 26. Neurol Ther. 2019. PMID: 31559584 Free PMC article.
-
The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology.Genome Res. 2017 Nov;27(11):1916-1929. doi: 10.1101/gr.218032.116. Epub 2017 Aug 30. Genome Res. 2017. PMID: 28855259 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical